Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
The 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands, 13–16 June 2019, saw hematology experts from around the globe congregate for a spectacular show of the latest research outputs.
Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.
EHA 2019
EHA 2019
The 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands, 13–16 June 2019, saw hematology experts from around the globe congregate for a spectacular show of the latest research outputs.
Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
